Enhabit — Investor Presentation (December 2024)

5 slides from Enhabit's investor presentation, Dec 5, 2024

Slide 1: Investor Presentation December 10, 2024
Investor Presentation December 10, 2024
Slide 2: Disclaimer: Forward looking statements
Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amen
Slide 3: Enhabit Home Health Volume Long-Term Outlook
Enhabit Home Health & Hospice 3 Enhabit Home Health Volume Long-Term Outlook Q3 2024 home health admissions continued to grow versus prior year, and we expect to continue growing at mid- to high- single digits over the next three years with our ability to better serve referral sources through improv
Slide 4: Enhabit Hospice Volume Long-Term Outlook
Enhabit Home Health & Hospice 4 Enhabit Hospice Volume Long-Term Outlook Expect hospice volumes to grow at mid- to high-single digits over the next three years after investing in the case management model and the build out of business development team Sequential monthly growth in census +91 +32 +11+
Slide 5: Enhabit Home Health & Hospice 2025 Pricing Impact
Enhabit Home Health & Hospice 5 Enhabit Home Health & Hospice 2025 Pricing Impact (based on 2024 volumes) $19-21 million expected increase to revenue based on 2025 pricing Home Health $11-13 million estimated revenue from the impact of the 2025 final rule* on Fee for Service Medicare, Non-Medicare E